The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Drug delivery to solid tumors by elastin-like polypeptides
Open accessAbstract
Thermally responsive elastin-like polypeptides (ELPs) are a promising class of recombinant biopolymers for the delivery of drugs and imaging agents to solid tumors via systemic or local administration. This article reviews four applications of ELPs to drug delivery, with each delivery mechanism designed to best exploit the relationship between the characteristic transition temperature (Tt) of the ELP and body temperature (Tb). First, when Tt >> Tb, small hydrophobic drugs can be conjugated to the C-terminus of the ELP to impart the amphiphilicity needed to mediate the self-assembly of nanoparticles. These systemically delivered ELP-drug nanoparticles preferentially localize to the tumor site via the EPR effect, resulting in reduced toxicity and enhanced treatment efficacy. The remaining three approaches take direct advantage of the thermal responsiveness of ELPs. In the second strategy, where Tb < Tt < 42 °C, an ELP-drug conjugate can be injected in conjunction with external application of mild hyperthermia to the tumor to induce ELP coacervation and an increase in concentration within the tumor vasculature. The third approach utilizes hydrophilic-hydrophobic ELP block copolymers that have been designed to assemble into nanoparticles in response to hyperthermai due to the independent thermal transition of the hydrophobic block, thus resulting in multivalent ligand display of a ligand for spatially enhanced vascular targeting. In the final strategy, ELPs with Tt < Tb are conjugated with radiotherapeutics, injtect intioa tumor where they undergo coacervation to form an injectable drug depot for intratumoral delivery. These injectable coacervate ELP-radionuclide depots display a long residence in the tumor and result in inhibition of tumor growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Biodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
Block copolymer micelles for drug delivery: design, characterization and biological significance
Kataoka, K., Harada, A., & Nagasaki, Y. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00124-1 · Cited by 3,506
Drug targeting using thermally responsive polymers and local hyperthermia
Meyer, D. E., Shin, B. C., Kong, G. A., Dewhirst, M. W., & Chilkoti, A. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00319-4 · Cited by 416 · cited 1×
“In a second “thermal targeting” strategy that builds on the first approach, ELPs can be designed to exhibit a Tt between 37 °C and 42 °C; systemic delivery of these ELPs in combination with externally applied, local hyperthermia to a solid tumor leads to enhanced tumor accumulation as compared to passive EPR-driven ac…”
BackgroundSelf-citation
Cited by
Lu, Y., Aimetti, A. A., Langer, R., & Gu, Z. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.75 · Cited by 1,421
Protein-based nanocarriers as promising drug and gene delivery systems
Elzoghby, A. O., Samy, W. M., & Elgindy, N. A. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.036 · Cited by 852
Wolinsky, J. B., Colson, Y. L., & Grinstaff, M. W. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.11.031 · Cited by 845
Polymeric Conjugates for Drug Delivery
Larson, N., & Ghandehari, H. (2012) · Chemistry of Materials · doi:10.1021/cm2031569 · Cited by 580
Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications
Spicer, C. D., Jumeaux, C., Gupta, B., & Stevens, M. M. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00877e · Cited by 497
Eskandari, S., Guerin, T., Toth, I., & Stephenson, R. J. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.013 · Cited by 381
Probing and engineering liquid-phase organelles
Bracha, D., Walls, M. T., & Brangwynne, C. P. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0341-6 · Cited by 318
Elastin‐like polypeptides as models of intrinsically disordered proteins
Roberts, S., Dzuricky, M., & Chilkoti, A. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.08.029 · Cited by 310
Self-citationProtein Nanoparticles: Promising Platforms for Drug Delivery Applications
Jain, A., Singh, S. K., Arya, S. K., Kundu, S. C., & Kapoor, S. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b01098 · Cited by 308
Elastin-Like Polypeptides for Biomedical Applications
Varanko, A. K., Su, J. C., & Chilkoti, A. (2020) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-092419-061127 · Cited by 291
Self-citationStimuli-Responsive Materials for Tissue Engineering and Drug Delivery
Municoy, S., Álvarez Echazú, M. I., Antezana, P. E., Galdopórpora, J. M., Olivetti, C., Mebert, A. M., Foglia, M. L., Tuttolomondo, M. V., Alvarez, G. S., Hardy, J. G., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134724 · Cited by 289
Probing and Manipulating Noncovalent Interactions in Functional Polymeric Systems
Chen, J., Peng, Q., Peng, X., Zhang, H., & Zeng, H. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00215 · Cited by 272
Engineered in-situ depot-forming hydrogels for intratumoral drug delivery
Fakhari, A., & Anand Subramony, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.11.014 · Cited by 164
Metadata
- Authors
- McDaniel, J. R., Callahan, D. J., & Chilkoti, A.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2010-12
- Volume
- 62
- Issue
- 15
- Pages
- 1456-1467
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2093985321
- Cited by
- 217
- References
- 4
- FWCI
- 0.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.